Edwards Life Reaches New 52-Week High (EW)

NEW YORK ( TheStreet) -- Edwards Life (NYSE: EW) hit a new 52-week high Wednesday as it is currently trading at $105.15, above its previous 52-week high of $105 with 400,421 shares traded as of 9:45 a.m. ET. Average volume has been one million shares over the past 30 days.

Edwards Life has a market cap of $11.58 billion and is part of the health care sector and health services industry. Shares are up 39.5% year to date as of the close of trading on Tuesday.

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases or critically ill patients worldwide. The company has a P/E ratio of 49.3, below the average health services industry P/E ratio of 50.8 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Edwards Life as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full Edwards Life Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing